Furthermore, in two large cohort studies, cinacalcet was shown to reduce overall and CV mortality in adult patients with PTH > 300 pg/mL [47] and adult patients with moderate sHPT (PTH 300–599 pg/mL), younger age, and without diabetes [48]. The gene discussed is PTH; the disease is diabetes mellitus.